cetylpyridinium chloride anhydrous and Graves Disease

cetylpyridinium chloride anhydrous has been researched along with Graves Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham-Nordling, M; Calissendorff, J; Hamberger, B; Lundell, G; Tallstedt, L; Törring, O; Wallin, G	1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and Graves Disease

Article	Year
Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid : official journal of the American Thyroid Association, 2005, Volume: 15, Issue:11 Topics: Adult; Aging; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Health; Humans; Iodine Radioisotopes; Male; Mental Health; Middle Aged; Quality of Life; Recurrence; Social Behavior; Surveys and Questionnaires; Sweden; Thyroidectomy; Thyrotropin	2005

Article

Year

Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery.

Thyroid : official journal of the American Thyroid Association, 2005, Volume: 15, Issue:11

Topics: Adult; Aging; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Health; Humans; Iodine Radioisotopes; Male; Mental Health; Middle Aged; Quality of Life; Recurrence; Social Behavior; Surveys and Questionnaires; Sweden; Thyroidectomy; Thyrotropin

2005